NASDAQ:VKTX

Viking Therapeutics Stock News

etoro logo Buy VKTX
*Your capital is at risk
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026

Is Viking Therapeutics a Smart Buy on the Dip?

05:47am, Monday, 27'th Mar 2023
Shares of Viking Therapeutics fell 25.2% during the week that ended March 24. Viking Pharmaceuticals fell in sympathy with Adaptimmune, which is developing a similar anti-obesity medication.

Viking Therapeutics: Some Caution Warranted

02:43pm, Thursday, 16'th Mar 2023
Biotech name Viking Therapeutics is going back into the spotlight for the first time in nearly a year in today's focus article. Thanks mainly to promising results from a competitor in the NASH space,
SAN DIEGO , March 7, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an
Viking Therapeutics, Inc. (NASDAQ:VKTX ) Q4 2022 Results Conference Call February 8, 2023 4:30 AM ET Company Participants Stephanie Diaz - Investor Relations Brian Lian - President and Chief Executive
The fourth quarter of 2022 was relatively better for the stock markets, with the S&P 500 up over 7% (its only positive quarterly return for the year).
Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well.

Why Did Viking Therapeutics Stock Skyrocket

10:08am, Wednesday, 21'st Dec 2022
VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.
Shares of Viking Therapeutics Inc. VKTX, +4.42% jumped 55% in premarket trading on Monday after a company that is also developing a selective thyroid hormone receptor beta agonist as a treatment for n
Competitor with similar mechanism of action drug resmetirom will release results from its phase 3 MAESTRO-NASH study in Q4 of 2022. Biopsy data is going to be key for success. Viking Therapeutics will
Viking Therapeutics, Inc. (VKTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Penny stocks to watch with unusual options activity this week. The post 10 Top Penny Stocks With Unusual Options Activity, Time To Buy?
Penny stocks to watch with unusual options activity this week. The post 7 Top Penny Stocks With Unusual Options Activity, Time To Buy?
Viking Therapeutics, Inc. (NASDAQ:VKTX ) Q3 2022 Earnings Conference Call October 26, 2022 4:30 PM ET Company Participants Stephanie Diaz - Manager, Investor Relations Brian Lian - President & Chief E
Penny stocks to buy according to analysts in 2022. The post 10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
Penny stocks to buy according to analysts in 2022. The post 7 Penny Stocks To Buy According To Top Wall Street Analysts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE